The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 09, 2016
Filed:
Apr. 16, 2014
Applicant:
Celgene Avilomics Research, Inc., Bedford, MA (US);
Inventors:
Juswinder Singh, Ashland, MA (US);
Russell Petter, Stow, MA (US);
Richland Wayne Tester, Marlborough, MA (US);
Arthur F. Kluge, Lincoln, MA (US);
Hormoz Mazdiyasni, Marlborough, MA (US);
William Frederick Westlin, III, Boxborough, MA (US);
Deqiang Niu, Lexington, MA (US);
Lixin Qiao, Tewksbury, MA (US);
Assignee:
Celgene Avilomics Research, Inc., Cambridge, MA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/505 (2006.01); C07D 495/04 (2006.01); C07D 239/47 (2006.01); C07D 239/48 (2006.01); C07D 401/14 (2006.01); C07D 403/12 (2006.01); C07D 407/12 (2006.01); C07D 413/12 (2006.01); C07D 413/14 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 487/18 (2006.01); A61K 31/506 (2006.01); A61K 31/519 (2006.01); A61K 31/5377 (2006.01); A61K 31/538 (2006.01); A61K 31/541 (2006.01); A61K 45/06 (2006.01); C07D 401/12 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01); C07D 487/08 (2006.01);
U.S. Cl.
CPC ...
C07D 495/04 (2013.01); A61K 31/505 (2013.01); A61K 31/506 (2013.01); A61K 31/519 (2013.01); A61K 31/538 (2013.01); A61K 31/5377 (2013.01); A61K 31/541 (2013.01); A61K 45/06 (2013.01); C07D 239/47 (2013.01); C07D 239/48 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/12 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 407/12 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 487/08 (2013.01); C07D 487/18 (2013.01);
Abstract
The present invention provides 2,4-disubstituted pyrimidine compounds useful as kinase inhibitors, pharmaceutically acceptable compositions thereof, and methods of using the same.